1X10^6 C57BL/6 mouse splenocytes were surface stained with 0.20 ug APC-Anti-Mouse CD3ε (APC-65060, clone 145-2C11) (red) or 0.20 ug APC-Hamster IgG isotype control (blue). Cells were not fixed.
1X10^6 C57BL/6 mouse bone marrow cells were surface stained with 0.13 ug APC Anti-Mouse Ly-6G (Gr-1) (APC-65140, Clone: RB6-8C5) (red) or 0.13 ug isotype control antibody (blue). Cells were not fixed.
1X10^6 TF-1 cells were surface stained with 10.00 ul/test APC Anti-Human CD117 (APC-65154, Clone:104D2) (red) or isotype control antibody (blue). Cells were not fixed.
1X10^6 human peripheral blood granulocytes were surface stained with 5.00 ul APC Anti-Human CD11b (APC-65116, Clone:ICRF44) (red) or isotype control antibody (blue). Cells were not fixed.
100 ul human peripheral blood were surface stained with 5.00 ul APC Anti-Human CD11c (APC-65086, Clone:3.9) and then treated with red blood cell lysis buffer. Cells were not fixed.
100 ul human peripheral blood were surface stained with 0.25 ug APC-mouse IgG1 isotype control and then treated with red blood cell lysis buffer. Cells were not fixed.
1X10^6 human peripheral blood granulocytes were surface stained with 10.00 ul/test APC Anti-Human CD13 (APC-65186, Clone:WM15) (red) or isotype control antibody (blue). Cells were not fixed.
1X10^6 human peripheral blood lymphocytes were surface stained with 0.25 ug FITC Anti-Human CD4 (FITC-65143, Clone: RPA-T4) and 0.25 ug APC Anti-Human CD161 (APC-65115, Clone: HP-3G10). Cells were not fixed.
1X10^6 human peripheral blood lymphocytes were surface stained with 0.25 ug FITC Anti-Human CD4 (FITC-65143, Clone: RPA-T4) and 0.25 ug APC-mouse IgG1 isotype control. Cells were not fixed.
